DIM and PSA Reduction: Blocking Aromatization for Prostate Health: A Case Report

Area of Science:

• Endocrinology
• Urology
• Nutraceutical Science

Background:

• A 78-year-old male patient presented with rising Prostate-specific antigen (PSA) and declining testosterone levels.
• Concerns about potential prostate pathology and patient's reluctance for biopsy led to a functional medicine approach.
• Hormonal imbalances were suspected as contributing factors to the patient's condition.

Purpose of the Study:

• To examine the effects of diindolylmethane (DIM) on PSA levels and hormonal balance.
• To explore a potential causal link between DIM use and hormonal changes.
• To assess the efficacy of a functional medicine approach in managing prostate health biomarkers.

Main Methods:

• Discontinuation of cholesterol-lowering supplements.
• Administration of 100 mg/day of DIM-Evail™ for three months.
• Monitoring of PSA and testosterone levels (total and free).

Main Results:

• PSA levels decreased from 4.6 to 2.4 ng/mL over three months.
• Total testosterone increased from 436 to 615 ng/dL.
• Free testosterone levels also showed a notable increase.

Conclusions:

• Targeted nutraceutical interventions like DIM show potential in modulating hormone metabolism.
• DIM may be a viable option for supporting prostate health and addressing hormonal imbalances.
• Further larger clinical studies are warranted to validate these findings.